JUVENILE DIABETES RESEARCH FOUNDATION LIMITED — grant history

Registered charity 295716 · filings on the Charity Commission register

Latest income

£8.0m

Grants listed (FY2025)

Listed grants total

£17.3m

Accounts grants total

£4.3m

listed grants do not fully reconcile with the accounts total — list may be partialextracted from its FY2025 accounts

Application guidance — from the funder’s own website

How to apply: Breakthrough T1D does not accept unsolicited grant applications. Funding is raised through public donations, fundraising events, and corporate partnerships rather than a formal application process for external grants.

Summarised from www.breakthrought1d.org.uk · breakthrought1d.org.uk/how-to-help/fundraise/ · breakthrought1d.org.uk/news-and-events/fundraising-events/ on 15/08/2026. Always check the funder’s site before applying.

What this funder supports

Based on the register classifications and operating areas of the grant recipients we could match to the charity register (a subset of all grantees).

Causes funded

The Advancement Of Health Or Saving Of Lives (7 grantees)
General Charitable Purposes (4 grantees)
Disability (4 grantees)
The Prevention Or Relief Of Poverty (3 grantees)
Education/training (3 grantees)
Accommodation/housing (2 grantees)
Economic/community Development/employment (2 grantees)
Religious Activities (1 grantee)
Environment/conservation/heritage (1 grantee)
Arts/culture/heritage/science (1 grantee)

Where grantees operate

Throughout England And Wales (6 grantees)
Scotland (2 grantees)
Northern Ireland (2 grantees)
Belgium (1 grantee)
Cheshire West & Chester (1 grantee)
Conwy (1 grantee)
Cardiff (1 grantee)
Denmark (1 grantee)
Flintshire (1 grantee)
Denbighshire (1 grantee)

Grants made, per its accounts filings

Download this grant history as CSV (open data, provenance and licence noted in the file).

Recipient	Year	Amount	Purpose
JDRF T1D Fund	FY2025	£3.2m	Improving Treg immunotherapy success by administering therapy at different times of day
SMF Grand Challenge	FY2025	£2.9m	Treg-sparing co-stimulation blockade: testing a novel immunosuppression strategy in people with Type 1 diabetes
JDRF T1D Fund	FY2025	£1.9m	Improving Treg immunotherapy success by administering therapy at different times of day
JDRF T1D Fund	FY2025	£1.3m	Improving Treg immunotherapy success by administering therapy at different times of day
JDRF T1D Fund	FY2025	£841k	Improving Treg immunotherapy success by administering therapy at different times of day
University of Birmingham	FY2025	£670k	PEG-Based Hydrogels for iPSCs-Derived Regenerative Therapies for Diabetes
University of Notre Dame US	FY2025	£423k	Translational Validation of Glucose-Responsive Insulin in Swine Models
University of Birmingham	FY2025	£386k	Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
JDRF T1D Fund	FY2025	£268k	Improving Treg immunotherapy success by administering therapy at different times of day
Donations £5,000 or less	FY2025	£267k	Support and awareness
Trustees of Indiana University	FY2025	£265k	Preventing hypoglycaemia through novel insulin-glucagon fusion proteins
University of Birmingham	FY2025	£250k	Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
University of Birmingham	FY2025	£223k	Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
Jinhua Institute of Zhejiang University	FY2025	£197k	A nano-sugar based artificial pancreas for the treatment of diabetes
University of Exeter	FY2025	£190k	Unlocking the translational potential of extreme forms of autoimmune diabetes by uncovering heterogeneous mechanisms of beta-cell autoimmunity
JDRF T1D Fund	FY2025	£171k	Improving Treg immunotherapy success by administering therapy at different times of day
University of Birmingham	FY2025	£150k	Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
University of Oxford	FY2025	£145k	Investigating the transcriptome of pancreatic islet delta-cells in type 1 diabetes for drug target identification and the prevention of severe hypoglycaemia
University of Birmingham	FY2025	£141k	Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
Turcan Connell	FY2025	£125k	Support and awareness
University of Birmingham	FY2025	£122k	Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
University of Dundee	FY2025	£105k	Sotagliflozin in Patients with Heart Failure Symptoms and Type 1 Diabetes (SOPHIST)
University of Cambridge	FY2025	£101k	Biological Signature of Diabetes Mellitus
The University of Edinburgh	FY2025	£101k	Macrophages To Promote The Long-Term Function Of Islets Following Transplantation For Type 1 Diabetes.
King's College London	FY2025	£101k	Exploring an islet-protective role for native pancreatic mesenchymal stromal cells in health and in type 1 diabetes
Cardiff University	FY2025	£100k	Microneedle arrays to deliver antigen specific immunotherapy
The Steve Morgan Foundation	FY2025	£100k	Grand Challenge establishment costs
The Steve Morgan Foundation	FY2025	£100k	Barrett Trial
University of Cambridge	FY2025	£98k	Novel dermal dressing loaded with a hydrogen sulphide donor for faster diabetic wound healing
Morrisons Foundation	FY2025	£95k	Support and awareness
Stanford University US	FY2025	£93k	Monomeric insulin formulations with fast onset and short duration of action
University of Birmingham	FY2025	£84k	Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
King's College London	FY2025	£82k	Exploring the translational potential of the NPY Y4 receptor for treating Type 1 Diabetes
University of Bristol	FY2025	£80k	Targeting the chemokine network in insulitis
University of Birmingham	FY2025	£77k	Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
Helmholtz Munich	FY2025	£72k	Immune-cloaking strategies for protection of stem cell derived beta cells in the human relevant pig model
University of Bristol	FY2025	£70k	Targeting the chemokine network in insulitis
University of Bristol	FY2025	£70k	Targeting the chemokine network in insulitis
Jinhua Institute of Zhejiang University	FY2025	£68k	A nano-sugar based artificial pancreas for the treatment of diabetes
University of Oxford	FY2025	£63k	Human Islets For Basic Research- Oxford JDRF Human Islet Resource Centre
University of Bristol	FY2025	£59k	Targeting the chemokine network in insulitis
King's College London	FY2025	£55k	Modulation of brain fatty acid oxidation to improve hypoglycemia counterregulation
University of Birmingham	FY2025	£55k	Establishing the effectiveness, safety and acceptability of treatments to preserve beta cell function in people with type 1 diabetes (T1D)
University of Bristol	FY2025	£53k	Targeting the chemokine network in insulitis
University of Birmingham	FY2025	£53k	Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
University of Ulster	FY2025	£52k	Harnessing the glucose lowering actions of alpha-melanocyte stimulatory hormone as a potential new adjunctive therapy for people with type 1 diabetes mellitus
King's College London	FY2025	£51k	Harmonizing biomarkers in clinical trials of ustekinumab
University of Bristol	FY2025	£50k	Targeting the chemokine network in insulitis
University of Birmingham	FY2025	£49k	Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
University of Dundee	FY2025	£48k	Determining the impact of C-peptide testing in possible type 1 diabetes
University of Dundee	FY2025	£47k	Border Patrol: Exploring the islet-protective role of mesenchymal stromal cell-secreted products to defend against immune cell invasion in Type 1 diabetes
King's College London	FY2025	£45k	From pancreas to periphery: A study of B-cells
Michael Lewis Foundation	FY2025	£45k	Support and awareness
HollyHock Charity	FY2025	£45k	Support and awareness
Steve Morgan Foundation	FY2025	£45k	Support and awareness
The University of Edinburgh	FY2025	£45k	Using Deep Learning on Retinal Images to Predict Complications and Therapeutic responses in Type 1 Diabetes
University of Manchester	FY2025	£43k	Understanding the hepatic microenvironment to improve function and survival of transplanted pancreatic islets in diabetes
University of Birmingham	FY2025	£42k	Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
University of Bristol	FY2025	£41k	Pancreatic function; unanticipated insights into progression rate to type 1 diabetes
University of Bristol	FY2025	£39k	Targeting the chemokine network in insulitis
University of Bristol	FY2025	£38k	Targeting the chemokine network in insulitis
Wayne State University	FY2025	£35k	A nano-sugar based artificial pancreas for the treatment of diabetes
University of Birmingham	FY2025	£33k	Testing the feasibility and acceptability of Early Surveillance for Autoimmune diabetes: The ELSA Study
Wayne State University	FY2025	£32k	A nano-sugar based artificial pancreas for the treatment of diabetes
Stanford University US	FY2025	£32k	Monomeric insulin formulations with fast onset and short duration of action
Tarrisse-Murphy Foundation	FY2025	£30k	Research Grants
University of Birmingham	FY2025	£29k	Development of 4 antibody multiplex assays for type 1 diabetes screening
University of Bristol	FY2025	£25k	Targeting the chemokine network in insulitis
University of Bristol	FY2025	£25k	Targeting the chemokine network in insulitis
University of Birmingham	FY2025	£25k	Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
University of Bristol	FY2025	£25k	Targeting the chemokine network in insulitis
University of Birmingham	FY2025	£25k	Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
Donations £5,000 or less	FY2025	£19k	Support and awareness
University of Birmingham	FY2025	£16k	Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
Imperial College London	FY2025	£16k	impact to stratify risk (RELOAD)
University of Dundee	FY2025	£15k	GlucoseCo: Co-developing a simple reference heatmap for predicting hypoglycemia risk during exercise for people with type 1 diabetes
University of Bristol	FY2025	£13k	Targeting the chemokine network in insulitis
Lancaster University	FY2025	£12k	Development of a point of care immunosensor for c-peptide assessment
Queen's University Belfast	FY2025	£12k	My T1D Care Tool: Co-Creating a digital psychosocial measure for young people living with Type 1 Diabetes as part of routine healthcare management
Grocers Charity	FY2025	£12k	Support and awareness
The Elizabeth & Prince Zaiger Trust	FY2025	£10k	Research Grants
Sir Samuel Scott	FY2025	£10k	Research Grants
Michael Lewis Foundation	FY2025	£10k	Research Grants
HollyHock Charity	FY2025	£10k	Research Grants
University of Birmingham	FY2025	£10k	Exploring the feasibility of an immunotherapy infusion service for type 1 diabetes prevention in the UK NHS setting.
Donations £5,000 or less	FY2025	£8k	Support and awareness
University of Bristol	FY2025	£6k	Targeting the chemokine network in insulitis
THE Inman Charity	FY2025	£5k	Research Grants
Donations £5,000 or less	FY2025	£5k	Support and awareness
Donations £5,000 or less	FY2025	£5k	Support and awareness
Campbell Batchworth Trust	FY2025	£5k	Research Grants
THE Thriplow Charity	FY2025	£5k	Research Grants
De Laslow Foundation	FY2025	£5k	Research Grants
Donations £5,000 or less	FY2025	£5k	Support and awareness
Lindsays LLP	FY2025	£3k	Research Grants
University of Birmingham	FY2025	£3k	Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
Donations £5,000 or less	FY2025	£1k	Research Grants
University of Bristol	FY2025	£1	Targeting the chemokine network in insulitis
University of Exeter	FY2024	£373k	Nicholas Thomas - Determining the impact of C-peptide testing in possible type 1 diabetes
University of Birmingham	FY2024	£302k	Lea Milligan / Leslie Johnson
University of Exeter	FY2024	£212k	Paul Weightman Potter - Modulation of brain fatty acid oxidation to improve hypoglycemia counterregulation
University of Birmingham	FY2024	£197k	2021 Adjustment to project fund
University of Cambridge	FY2024	£161k	Eoin McKinney - TrialNet Transcriptomic Pipeline
University of Birmingham	FY2024	£150k	James Pearson
University of Exeter	FY2024	£146k	Chloe Rackham - Exploring an islet-protective role for native pancreatic mesenchymal stromal cells in health and in type 1 diabetes
Uinversity of Edinburgh (Connect Immune Research award)	FY2024	£145k	Yannick Crow - Precision type I interferon biomarkers for the stratification of autoimmune disease
University of Birmingham	FY2024	£144k	Connect Immune Research and Loran and Yuti Chernajovsky Biomedical Research Foundation Awards 2022
University of Birmingham	FY2024	£121k	Improving Treg immunotherapy success by administering therapy at different times of day
Helmholtz Munich	FY2024	£120k	Matthias Hebrok - Immune-cloaking strategies for protection of stem cell derived beta cells in the human relevant pig model
University of Exeter	FY2024	£102k	Paul W Potter - Modulation of brain fatty acid oxidation to improve hypoglycemia counterregulation
University of Ulster	FY2024	£101k	Alexander Miras - Harnessing the glucose lowering actions of alpha-melanocyte stimulatory hormone as a potential new adjunctive therapy for people with type 1 diabetes mellitus
King's College London	FY2024	£101k	Stephanie Amiel - A Hypoglycemia Awareness Restoration Program for people with type 1 diabetes and problematic hypoglycemia persisting
Cardiff University	FY2024	£100k	Colin Dayan - Microneedle arrays to deliver antigen specific immunotherapy
The University of Edinburgh	FY2024	£100k	Shareen Forbes - Macrophages To Promote The Long-Term Function Of Islets Following Transplantation For Type 1 Diabetes.
University of Exeter	FY2024	£98k	Matthew Johnson - Unlocking the translational potential of extreme forms of autoimmune diabetes by uncovering heterogeneous mechanisms of beta-cell autoimmunity
University of Birmingham	FY2024	£93k	SMF Grand Challenge - Treg-sparing co-stimulation blockade: testing a novel immunosuppression strategy in people with Type 1 diabetes
Cardiff University	FY2024	£89k	Colin Dayan - The beta-2 score and beyond: new composite outcomes measures of islet cell function for use in clinical trials
King's College London	FY2024	£82k	Timothy Tree - Harmonizing biomarkers in clinical trials of ustekinumab
University of Birmingham	FY2024	£78k	Testing the feasibility and acceptability of EarLy Surveillance for Autoimmune diabetes: The ELSA Study
University of Birmingham	FY2024	£70k	PI / VERSUSAR - INV00897 February 2023
University of Birmingham	FY2024	£68k	MQ Foundation - Emory University - Adapting and testing an integrated care model for treatment of Type 1 diabetes and mental health co- morbidities
University of Bristol	FY2024	£63k	Anna Long - Adult onset Type 1 Diabetes: Slow Progressors or Late Starters?
University of Birmingham	FY2024	£59k	Alex Ritcher - Using neuroimaging to understand the role of cognitions in restoring hypoglycemia awareness in adults with type 1 diabetes and impaired awareness of hypoglycemia
University of Birmingham	FY2024	£58k	Generation of high insulin producing beta cells from human pluripotent stem cells
University of Oxford	FY2024	£55k	Paul Johnson - Human Islets For Basic Research- Oxford JDRF Human Islet Resource Centre
The University of Edinburgh	FY2024	£52k	Helen Colhoun - Using Deep Learning on Retinal Images to Predict Complications and Therapeutic responses in Type 1 Diabetes
University of Bristol	FY2024	£51k	Kathleen Gillespie - COVID-19 antibody screening in families with type 1 diabetes: infection rate and effects on diabetes
University of Birmingham	FY2024	£50k	James Pearson
University of Birmingham	FY2024	£50k	Julie Cawley / Rocio Sancho - PEG-Based Hydrogels for iPSCs-Derived Regenerative Therapies for Diabetes
University of Birmingham	FY2024	£49k	James Pearson
University of Dundee	FY2024	£47k	Ify Mordi - Sotagliflozin in Patients with Heart Failure Symptoms and Type 1 Diabetes (SOPHIST)
Queen's University Belfast	FY2024	£45k	Emma Berry - My T1D Care Tool: Co-Creating a digital psychosocial measure for young people living with Type 1 Diabetes as part of routine healthcare management
University of Exeter	FY2024	£44k	Joanne Boldison - From pancreas to periphery: A study of B-cells
University of Birmingham	FY2024	£42k	Development of 4 antibody multiplex assays for type 1 diabetes screening
University of Birmingham	FY2024	£38k	James Pearson
King's College London	FY2024	£36k	Gavin Bewick - Exploring the translational potential of the NPY Y4 receptor for treating Type 1 Diabetes
University of Birmingham	FY2024	£32k	James Pearson
University of Birmingham	FY2024	£25k	James Pearson
University of Birmingham	FY2024	£25k	James Pearson
University of Cambridge	FY2024	£20k	Kourosh Saeb-Parsy - Biological Signature of Diabetes Mellitus
University of Birmingham	FY2024	£16k	PI / MEDICALR - Daniel Doherty JDRF UK - Understanding the hepatic microenvironment to improve function and survival of transplanted pancreatic islets in diabetes
University of Birmingham	FY2024	£16k	Parth Narendran - Semaglutide as an add-on treatment to optimise glycaemic control in children and young people with type 1 diabetes
University of Birmingham	FY2024	£15k	Timothy Barrett - Mixed Methods study exploring the impact of hybrid closed loop systems on patient recorded outcomes in people with type 1 diabetes and their partners
Cardiff University	FY2024	£12k	Colin Dayan - Clinical Trials in the Type 1 Diabetes UK Immunotherapy Consortium: Bigger, Smarter, Faster
University of Birmingham	FY2024	£10k	P Choudhary - PI / UNIBRIST - 1 RPG 2020 0001 50% expenditure Jun 21(DUK) JDRF T1D Fund
University of Birmingham	FY2024	£3k	Danijela Tatovic
University of Birmingham	FY2024	£-5k	James Pearson
University of Exeter	FY2023	£384k	Exploring an islet-protective role for native pancreatic mesenchymal stromal cells in health and in type 1 diabetes
King's College London	FY2023	£373k	Improved, cost effective prediction of type 1 diabetes in early life using combined prediction models
University of Bristol	FY2023	£302k	PI / UNIBRIST - 1 RPG 2020 0001 50% expenditure Jun 21(DUK)
University of Birmingham	FY2023	£299k	Using neuroimaging to understand the role of cognitions in restoring hypoglycemia awareness in adults with type 1 diabetes and impaired awareness of hypoglycemia
University of Oxford	FY2023	£264k	Exploring the translational potential of the NPY Y4 receptor for treating Type 1 Diabetes
Cardiff University	FY2023	£174k	Microneedle arrays to deliver antigen specific immunotherapy
University of Birmingham	FY2023	£144k	Testing the feasibility and acceptability of EarLy Surveillance for Autoimmune diabetes: The ELSA Study
University of Birmingham	FY2023	£121k	Generation of high insulin producing beta cells from human pluripotent stem cells
University of Birmingham	FY2023	£120k	Development of 4 antibody multiplex assays for type 1 diabetes screening
King's College London	FY2023	£78k	Restoring hypoglycemia awareness through dishabituation
University of Bristol	FY2023	£55k	Determining the impact of C-peptide testing in possible type 1 diabetes
University of Dundee	FY2023	£51k	Human Islets For Basic Research- Oxford JDRF Human Islet Resource Centre
University of Exeter	FY2023	£50k	From pancreas to periphery: A study of B-cells
University of Exeter	FY2023	£50k	Modulation of brain fatty acid oxidation to improve hypoglycemia counterregulation
King's College London	FY2023	£43k	A Hypoglycemia Awareness Restoration Program for people with type 1 diabetes and problematic hypoglycemia persisting
University of Exeter	FY2023	£43k	TrialNet Transcriptomic Pipeline
The Lorna and Yuti Chernajovsky Biomedical Research Foundation	FY2023	£38k	Connect Immune Research and Loran and Yuti Chernajovsky Biomedical Research Foundation Awards 2022
University of Bristol	FY2023	£38k	PI / MEDICALR - Daniel Doherty JDRF UK Understanding the hepatic microenvironment to improve function and survival of transplanted pancreatic islets in diabetes
University of Birmingham	FY2023	£33k	Semaglutide as an add-on treatment to optimise glycaemic control in children and young people with type 1 diabetes
University of Birmingham	FY2023	£27k	COVID-19 antibody screening in families with type 1 diabetes: infection rate and effects on diabetes
University of Cambridge	FY2023	£18k	Modulation of brain fatty acid oxidation to improve hypoglycemia counterregulation
University of Edinburgh	FY2023	£16k	Adult onset Type 1 Diabetes: Slow Progressors or Late Starters? (Connect Immune Research award)
University of Bristol	FY2023	£16k	Harmonizing biomarkers in clinical trials of ustekinumab
Emory University	FY2023	£13k	JDRF T1D Fund
University of Exeter	FY2023	£5k	Precision type I interferon biomarkers for the stratification of autoimmune disease

About this data

This grant list is extracted by automated reading of the grant-maker’s own accounts PDFs as filed with the Charity Commission, and cross-checked against the accounts’ stated grant totals (listed sum 17287164 vs reference 4300000 (302.0% diff; ref=stated)). Recipients are linked to register entries only on an exact charity-number or unambiguous exact-name match. If you represent this funder and want a correction, contact us.